Gilderm Plus Cream is a topical formulation combining Ofloxacin (0.75% w/w), Ornidazole (2% w/w), Itraconazole (1% w/w), and Clobetasol (0.05% w/w) designed for the effective management of mixed bacterial, protozoal, fungal infections, and inflammatory dermatoses. Ofloxacin, a broad-spectrum fluoroquinolone antibiotic, targets susceptible Gram-positive and Gram-negative bacteria by inhibiting DNA gyrase, thereby preventing bacterial replication. Ornidazole, a nitroimidazole derivative, exhibits potent activity against anaerobic protozoa and bacteria by disrupting DNA synthesis. Itraconazole, a triazole antifungal agent, inhibits ergosterol synthesis essential for fungal cell membrane integrity, providing broad antifungal coverage. Clobetasol propionate, a super potent corticosteroid, exerts anti-inflammatory, antipruritic, and vasoconstrictive effects, reducing inflammation and immune response in affected skin areas. The combination therapy is indicated for dermatological conditions involving mixed infections where inflammation is prominent, such as complicated dermatoses, infected eczema, and certain fungal-bacterial co-infections. Gilderm Plus Cream should be applied topically as directed by a healthcare professional, avoiding prolonged use to minimize potential adverse effects associated with potent corticosteroids, including skin atrophy and systemic absorption. Contraindications include hypersensitivity to any component and viral skin infections. Use under medical supervision is recommended to ensure appropriate diagnosis and treatment monitoring.